Two people can lose the same percentage of body weight and finish at different body-size measurements. A CagriSema analysis explored whether absolute anthropometric targets could add information to percentage change. For a reader setting goals, the useful distinction is between a research threshold and an individualized clinical target.
The analysis examined two targets together
The secondary, post hoc REDEFINE 1 analysis evaluated body mass index below 27 and waist-to-height ratio below 0.53. At week 68, 30.3% of combination recipients achieved both targets, compared with 3.3% receiving placebo. It also examined relationships with selected glucose, blood-pressure and lipid outcomes. See the primary analysis published in 2026.
These are study-defined thresholds, not a declaration that every person should pursue those exact numbers. The paper describes an exploratory way of interpreting outcomes and calls for further validation. The post hoc label should remain visible whenever its findings are summarized.
Understand why starting point changes the question
As a mathematical illustration, two people who each lose 10% of their starting weight need not cross the same BMI threshold. Likewise, an identical percentage change does not establish the same waist measurement. Percentage change describes movement relative to a starting value; an absolute target describes where someone finishes.
Both views can be informative, but neither alone describes every outcome a person values. A consultation can consider body-size measures alongside the actual health concern and the practical experience of treatment, rather than treating one threshold as the sole definition of success.
Association does not establish the complete causal story
The analysis examined how reaching anthropometric targets related to selected cardiometabolic measures. It did not randomize people to achieve one waist-to-height ratio rather than another. Therefore, the relationship should not become a claim that crossing a particular cutoff itself guarantees a clinical benefit.
This distinction matters when an article links a body-size target to a promise about disease prevention. The required evidence for the prevention claim is more demanding than an association within a treatment study.
Use targets to support a conversation
Ask which measurements would be relevant to your situation, how they would be collected consistently and how they would change the care plan. Also ask how improvement would be recognized if a particular threshold were not reached.
The value of this research is a more nuanced discussion of progress. It does not establish a universal cutoff, a guaranteed result or a reason to intensify treatment independently. Keep the analysis’s exploratory status attached to its numbers and let clinical context determine which goals are meaningful.
Sources and reading scope
Research draft prepared November 7, 2026. This is educational synthesis, not medical review or an individualized treatment recommendation. Check the linked original records and current labels before making a decision.